Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
1 Am J Gastroenterol
2 BMC Gastroenterol
3 Eur J Gastroenterol Hepatol
1 Inflamm Bowel Dis
4 J Crohns Colitis
2 Lancet Gastroenterol Hepatol
1 Proc Natl Acad Sci U S A
1 Scand J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. PASVOL TJ, Bloom S, Segal AW, Rait G, et al
    Use of contraceptives and risk of inflammatory bowel disease: A nested case-control study.
    Aliment Pharmacol Ther. 2021 Oct 18. doi: 10.1111/apt.16647.
    PubMed         Abstract available

    Am J Gastroenterol

  2. THAKUR K, Barrett TA
    Social Determinants of Health in Inflammatory Bowel Diseases: Barriers and Opportunities.
    Am J Gastroenterol. 2021;116:2146.

    BMC Gastroenterol

  3. YAO JY, Zhang M, Wang W, Peng X, et al
    Ustekinumab trough concentration affects clinical and endoscopic outcomes in patients with refractory Crohn's disease: a Chinese real-world study.
    BMC Gastroenterol. 2021;21:380.
    PubMed         Abstract available

  4. WANG H, Wu Y, Ye C, Liu Z, et al
    Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn's disease: a ten-year hospital-based observational study in China.
    BMC Gastroenterol. 2021;21:376.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  5. PUTIGNANI L, Oliva S, Isoldi S, Del Chierico F, et al
    Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases.
    Eur J Gastroenterol Hepatol. 2021;33:1376-1386.
    PubMed         Abstract available

  6. GREENER T, Boland K, Milgrom R, Ben-Bassat O, et al
    Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients.
    Eur J Gastroenterol Hepatol. 2021;33:1274-1279.
    PubMed         Abstract available

  7. TURSI A, Florio T, Tiano M
    Successful treatment of concomitant Crohn's disease and psoriasis with risankizumab.
    Eur J Gastroenterol Hepatol. 2021;33:1462-1464.

    Inflamm Bowel Dis

  8. KING D, Chandan JS, Thomas T, Nirantharakumar K, et al
    The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2021;27:1731-1739.
    PubMed         Abstract available

    J Crohns Colitis

  9. DAI C, Jiang M, Huang YH
    Anti-Tubercular Therapy on the Long-Term Disease Course of Patients with Crohn's disease.
    J Crohns Colitis. 2021;15:169.

  10. MAASER C, Kucharzik T, Gecse K
    Is Intestinal Ultrasound Ready to be Used as Standard Monitoring Tool in Daily Practice and as Endpoint in Clinical Trials?
    J Crohns Colitis. 2021;15:1-2.

  11. KUCHARZIK T, Maaser C, Maconi G
    A Simple Intestinal Ultrasound Score in Crohn's Disease: First Big Step Towards New Paradigms.
    J Crohns Colitis. 2021;15:3-4.

  12. CHARKAOUI M, Hajage D, Tubach F, Laurent B, et al
    Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study.
    J Crohns Colitis. 2021 Oct 18. pii: 6399096. doi: 10.1093.
    PubMed         Abstract available


  13. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.

    Lancet Gastroenterol Hepatol

  14. SELIM R, Wellens J, Marlow L, Satsangi JJ, et al
    SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
    Lancet Gastroenterol Hepatol. 2021 Oct 13. pii: S2468-1253(21)00347.

  15. ALEXANDER JL, Selinger CP, Powell N
    Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2021 Oct 12. pii: S2468-1253(21)00374.

    Proc Natl Acad Sci U S A

  16. LANDUYT AE, Klocke BJ, Duck LW, Kemp KM, et al
    ICOS ligand and IL-10 synergize to promote host-microbiota mutualism.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    Scand J Gastroenterol

  17. SHIMODAIRA Y, Watanabe K, Fukuda S, Watanabe N, et al
    Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Scand J Gastroenterol. 2021 Oct 18:1-4. doi: 10.1080/00365521.2021.1991467.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.